Author: Syn Bio Australasia

Synbio profile interview – Alison McLennan

 

McLennan1.jpgDr Alison McLennan is an Assistant Professor at Faculty of Business, Government and Law, University of Canberra. Alison is particularly interested in the challenges posed to regulation by emerging technologies, especially biotechnologies. Her PhD investigated regulation of synthetic biology and was awarded in 2014. In 2017, she presented the legal issues relating to synthetic biology at the SBA conference held in Sydney. She has continued to publish work on SynBio regulation and patent law, including for general audiences via The Conversation, and has a new book about synthetic biology law and policy issues coming out in 2018. Alison is interested in how we can not only manage the risks of new technologies, but also maximise their potential benefits. Twitter handle: @asmclennan

Continue reading “Synbio profile interview – Alison McLennan”

Synbio profile interview – Karen Weynberg

Karen WeynbergWe are excited to present synthetic biologist, Dr Karen Weynberg, who is the ECR representative of SBA Executive Board. Karen is a CSIRO Future Science Research Fellow based at University of Queensland.

She completed her PhD in the UK in 2009, uncovering new viruses that infect marine phytoplankton. Her first fellowship, the ARC Super Science Research Fellowship, investigated the role of viruses in coral reefs. Her current fellowship uses synthetic biology to develop phage therapy for addressing bacterial biofilms and antibiotic resistance. Suffice to say that  Karen is something of a virus aficionado, and has even given a TedX talk and media interviews to  BBC News and ABC News. Twitter handle: @ReefViruses

Continue reading “Synbio profile interview – Karen Weynberg”

CRISPR-Cas9 genome editing: from Cancer Treatment to Agriculture

by Jestin George

Crispr banner
CRISPR-Cas9 editing of the genome from NIH image gallery (Creative Commons CC2.0 from Flickr)

In 2012 the first evidence of CRISPR-Cas9 genome editing was published and since then, almost 4000 CRISPR-Cas9 articles have followed. From fundamental research to applications in biotechnology, agriculture, health care, pest control, and synthetic biology, there is no doubt that CRISPR systems will revolutionise both biological research and indeed, technology, as we know it. Continue reading “CRISPR-Cas9 genome editing: from Cancer Treatment to Agriculture”